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 Visualizing p63+ cells facilitated to trace the epithelial differentiation. 1 
 Isolating p63+ cells during differentiation enabled epithelial stem cell research. 2 
 p63 knock-in human iPS cells apply for the studies of epithelial cell lineages. 3 
 4 
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Abstract 7 
The p63 is a biomarker whose expression in surface ectodermal cells during 8 
developmental processes of the cornea, skin, oral mucosa, and olfactory 9 
placodes and is indispensable for understanding the mechanisms of self-renewal 10 
and maintenance of epithelial stemness. Here, we generated a p63 knock-in (KI) 11 
human induced pluripotent stem (hiPS) cell line by using TALEN, where p63 12 
expression was visualized via enhanced green fluorescent protein expression. 13 
The established cells maintained pluripotency, and were found to be specifically 14 
targeted at the stem cell marker gene, ΔNp63α. The KI-hiPS cells successfully 15 
differentiated into corneal epithelial cells, and the functional epithelial stem cells 16 
through p63 expression were used to evaluate reconstruction of the corneal 17 
epithelium. This novel approach enables the tracing of cell lineages expressing 18 
3 
 
p63 from the early differentiation stage throughout epithelial development. 1 
Therefore, our data indicated that the p63-hiPS KI cells can be used as an 2 
effective tool extending beyond studies of epithelial cell lineages. 3 
 4 
1. Introduction 5 
p63 is expressed at surface ectodermal cells beginning in early development to 6 
facilitate formation of the epithelium, and to eventually maintain a stratified 7 
epithelial structure (Barbieri et al. 2006; Senoo et al. 2007; Melino et al. 2015) in 8 
the cornea, skin, oral mucosa, and olfactory placodes. p63 has two major 9 
isoforms, namely the transactivating (TAp63) and N-terminally truncated 10 
(ΔNp63) isoforms, each of which is driven by a different promoter and is 11 
alternatively spliced at the C-terminus to generate the alpha, beta, and gamma 12 
forms (Figure 1A). Of these, ΔNp63α is a well-established as a marker of 13 
epithelial stem cells, and is abundantly expressed in the basal layers of the 14 
corneal limbus and epidermis, where stem cells with high proliferative capability 15 
are present (Barbieri et al. 2006; Kawasaki et al. 2006; Robertson et al. 2008). 16 
Genome editing technology is sufficiently advanced as to potentially 17 
enable genetic modification for gene therapy, stem cell-based therapy, and 18 
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research into the biological mechanisms of intractable diseases (Byrne et al. 1 
2014). These technologies are based on zinc-finger nucleases (ZFNs) and 2 
transcription activator-like effector nucleases (TALENs) (Ochiai et al. 2010; 3 
Hockemeyer et al. 2011), which are engineered molecular scissors consisting of 4 
a site-specific DNA-binding domain fused to the non-specific nuclease domain 5 
of the restriction enzyme FokI. The clustered regularly interspaced short 6 
palindromic repeats (CRISPR) / Cas9 nuclease cleaves double-stranded DNA 7 
with the help of the RNA-guided Cas9 nuclease (Cong et al. 2013; Doudna and 8 
Charpentier. 2014). We have now used the TALEN system, which offers high 9 
cleavage efficiency and specificity (Guilinger et al. 2014) and infrequent off-10 
target events (Gabriel et al. 2011; Ding et al. 2013; Yusa 2013), to establish a 11 
p63 knock-in (KI) human induced pluripotent (hiPS) cell line. These cells 12 
enable, for the first time, tracking of corneal epithelial differentiation in vitro. 13 
Several reports have shown that gene edited KI-hiPS cells were terminally 14 
differentiated (Cerbini et al. 2015; Wu et al. 2016), however, tracking epithelial 15 
stem cell markers using KI cell lines has not been previously reported. 16 
Generation of the self-formed ectodermal autonomous multi-zone 17 
(SEAM), as achieved by Hayashi et al. (2016), demonstrated corneal epithelial 18 
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induction from hiPS cells. The ocular surface ectoderm generated by SEAM 1 
formation may potentially approach medical treatment for recovering corneal 2 
functions. The SEAM structure perfectly mimicked whole-eye development, and 3 
ocular surface ectodermal cells appeared in specific zones within 2–3 weeks, 4 
although the developmental timing and other mechanistic details remained 5 
unclear. The purpose of this study was to identify epithelial lineages by tracking 6 
p63 expression via an enhanced green fluorescence protein (EGFP) - fusion 7 
protein during differentiation. p63 represents an attractive candidate protein for 8 
elucidating the developmental mechanism of human epithelial stem cells, as it is 9 
expressed from the early developmental stage. We used this strategy to 10 
establish, for the first time, p63 KI-hiPS cells that enable tracing of epithelial 11 
development in vitro. 12 
The use of TALEN technology facilitated the production of p63 KI-hiPS 13 
cells, which served as a robust and versatile tool for investigating cell 14 
differentiation and for applications in corneal epithelial development. 15 
 16 
2. Materials and methods 17 
2.1 hiPS cell culture 18 
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The human iPS cell line 1383D2 was provided by the Center for iPS Cell 1 
Research and Application (CiRA), Kyoto University. The cells were grown in 2 
StemFit medium (Ajinomoto, Tokyo, Japan) on dishes coated with Laminin 3 
511E8 (nippi iMatrix-511, Wako), and passaged every 7 days, with a medium 4 
change performed every 2 days (Nakagawa et al. 2014). All experimental 5 
procedures using recombinant DNA were approved by the Recombinant DNA 6 
Committee of Osaka University. 7 
 8 
2.2 Construction of the donor vector and TALEN plasmids 9 
The donor vector was constructed such that a P2A-EGFP-neomycin cassette 10 
was flanked by human p63α homology arms (Fasmac, Kanagawa, Japan). A 11 
pair of hp63α TALENs was synthesized in GeneART® Precision TALs (Thermo 12 
Fisher Scientific, MA) and subcloned into the pEF5/FRT/V5-DEST vector 13 
(Thermo Fisher Scientific) using Gateway LR Clonase II (Thermo Fisher 14 
Scientific). Recombinant DNA and genome-editing protocols were approved by 15 
the research ethics committee of Osaka University. 16 
 17 
2.3 Cleavage efficiency of p63 TALENs 18 
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The TALEN plasmids were evaluated by performing an SSA assay (Sakuma et 1 
al. 2013). The pGL4-SSA reporter vector, containing an overlapped homologous 2 
luciferase gene was used to construct the pGL4-SSA-hp63α vector. As a 3 
positive control, pGL-SSA-HPRT1 was used with either HPRT1 TALENs or 4 
HPRT1-NC TALENs (kindly provided by T. Yamamoto, Hiroshima University). 5 
The TALEN plasmids, the pGL4-SSA reporter vector and the pRL-CMV 6 
reference vector (Promega, Madison, WI) were transfected into human 7 
embryonic kidney HEK293T cells by using Lipofectamine LTX (Thermo Fisher 8 
Scientific) in a 96-well plate. Luciferase activity was measured in a multilabel 9 
counter (ARVO MX, Perkin Elmer, MA) at 24 h post-transfection, using the 10 
Dual-Glo Luciferase Assay System (Promega) according to the manufacturer’s 11 
instructions. 12 
 13 
2.4 Establishment of hp63 KI hiPS cells 14 
Y-27632 (10 μM, Wako) was added to 1383D2 cells 3 h prior to electroporation.  15 
Electroporation conditions for 1383D2 cells were first optimized from 7 different 16 
protocols, using the pmax GFP plasmid as the test transgene. The most 17 
efficient protocol was selected based on the transfection efficiency. The donor 18 
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vector (5 μg) and TALEN plasmids (2.5 μg each) were mixed in Nucleofector 1 
solution P3 with supplement (4D-Nucleofector X Kit L, Lonza) and 2 
electroporated into 1  106 cells using the CB150 run program, according to the 3 
manufacturer’s recommended protocol. Cells were then plated on dishes coated 4 
with Laminin 511E8 and cultured in Stem Fit medium containing 10 μM Y-5 
27632. The medium was replaced on the following day with fresh StemFitTM 6 
medium containing 40 μg/mL neomycin. The optimal antibiotic concentration for 7 
clone selection was then determined by exposing untransfected cells to 0–100 8 
μg/mL neomycin 1 day after passage, and by selecting the minimum 9 
concentration that killed all cells in 7 days. After 12 to 14 days, neomycin-10 
resistant colonies were trypsinized, and seeded at 250 to 750 cells per 10-cm 11 
dish, pre-coated with Laminin 511-E8. Subsequently, individual colonies were 12 
picked and expanded in 12-well plates after 14 to 16 days. Genomic DNA from 13 
individual clones was extracted using the NucleoSpin® Tissue (Takara, Japan) 14 
and genotyped by PCR (T100 Thermal cycler, Bio-Rad, CA), using the primers 15 
hp63-external-F (5-TGAGGATGCCCTAAGTCCCT-3 and hp63-external-R (5-16 
AATCACCCCAACGTGAACCA-3). Targets were amplified by performing a hot 17 
start at 98℃ for 2 min and 35 cycles of denaturation at 98℃ for 10 s, 18 
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annealing at 66℃ for 30 s, and extension at 72℃ for 4 min and 45 s, followed 1 
by final extension at 72℃ for 10 min. PCR products were analyzed by 2 
electrophoresis on 0.8% agarose gels. Fragments of apparent size of 4,247 bp 3 
(KI) and 1,604 bp (WT) were sequenced, using an Applied Biosystems 3100 4 
Genetic Analyzer (Thermo Fisher Scientific). Clones were genotyped as wild 5 
type (WT), heterozygous (WT/KI), and homozygous (KI/KI). Only a homozygous 6 
KI clone was used for further analysis, with a WT clone used as a control. 7 
Frozen stocks were prepared in STEM-CELLBANKER cryoprotectant (Nippon 8 
Zenyaku Kogyo, Japan) at 2  105 live cells per tube. 9 
 10 
2.5 Western blot analysis of 2A peptide cleavage 11 
p63 KI-hiPS cells were harvested at 10 weeks of differentiation and analyzed by 12 
western blotting to assess 2A peptide cleavage between endogenous hp63α 13 
and the EGFP insert. After cells were lysed in RIPA lysis buffer (Nacalai, Japan), 14 
20 μg total protein was loaded on 4–12% Tris-Glycine SDS-PAGE gels, which 15 
were then blotted and probed with monoclonal antibodies against p63 (4A4, 16 
Santa Cruz, CA) and GAPDH (6C5, Santa Cruz), or with a polyclonal antibody 17 




2.6 Differentiation of hiPS cells into ocular ectodermal cells 2 
hiPS cells were induced to differentiate into ocular ectodermal cells, as 3 
previously described (Hayashi et al. 2016). Briefly, cells were seeded in dishes 4 
pre-coated with Laminin 511E8, and grown in StemFitTM medium for 8 to 12 5 
days, starting on day 0. For ocular differentiation, the medium was then 6 
replaced with differentiation medium (DM) based on Glasgow-MEM (Thermo 7 
Fisher Scientific) supplemented with 10% knockout serum replacement 8 
(Thermo Fisher Scientific), 1 mM sodium pyruvate (Thermo Fisher Scientific), 9 
0.1 mM non-essential amino acids (Thermo Fisher Scientific), 2 mM L-10 
glutamine (Thermo Fisher Scientific), 1% penicillin-streptomycin, and 55 μM 2-11 
mercaptoethanol (Thermo Fisher Scientific) or monothioglycerol (Wako Osaka, 12 
Japan). After 4 weeks, cells were cultured for another 4 weeks in CDM (diluted 13 
1:1 in DM and Cnt-PR (without EGF and FGF2) (CELLnTEC Advanced Cell 14 
Systems, Bern, Switzerland) supplemented 20 ng/mL KGF (Wako), 10 μM Y-15 
27632 (Wako), and 1% penicillin-streptomycin. After differentiation for 6 - 8 16 
weeks, non-epithelial cells were removed by manual pipetting under a 17 
microscope. To further differentiate cells into corneal epithelium, they were then 18 
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cultured for an additional 4 weeks in corneal epithelium maintenance medium 1 
(CEM; DMEM/F12 [2:1]), Thermo Fisher Scientific) containing 2% B27 2 
supplement (Thermo Fisher Scientific), 20 ng/ml KGF, 10 μM Y-27632, and 1% 3 
penicillin-streptomycin. 4 
 5 
2.7 Flow cytometry and cell sorting 6 
KI-hiPS cells were differentiated for 10–12 weeks, dissociated with Accutase 7 
(Thermo Fisher Scientific) for 60 to 90 min at 37℃, harvested through a 40-μm 8 
cell strainer (BD Biosciences, San Diego, CA), and collected into corneal 9 
epithelium maturation medium (KCM medium, a 3:1 mix of DMEM without 10 
glutamine and Nutrient Mixture F-12 Ham; Thermo Fisher Scientific) 11 
supplemented with 5% fetal bovine serum (Japan Bio Serum, Hiroshima, 12 
Japan), 0.4 μg/mL hydrocortisone succinate (Wako), 2 nM 3,3′,5-triiodo-l-13 
thyronine sodium salt (MP Biomedicals, Santa Ana, CA), 1 nM cholera toxin 14 
(List Biological Laboratory, Campbell, CA), 2.25 μg/mL bovine transferrin HOLO 15 
form (Thermo Fisher Scientific), 2 mM L-glutamine, 0.5% insulin transferrin 16 
selenium (Thermo Fisher Scientific), and 1% penicillin-streptomycin). Cells were 17 
washed in phosphate-buffered saline, and stained with antibodies against 18 
12 
 
SSEA-4 (MC-81370; BioLegend) and ITGB-4 (CD104; 58XB4, BioLegend) as 1 
described (Hayashi et al. 2016). Isotype-matched IgG and IgM antibodies were 2 
used as negative controls. Cells were sorted on a SH800 Cell Sorter (Sony 3 
Biotechnology Inc., Japan), and the data were analyzed using SH800 and 4 
FlowJo software (TreeStar, San Carlos, CA). Cell expressing EGFP, SSEA-4, 5 
and ITGB-4 (hiCECs) were seeded in a temperature responsive-dish (CellSeed, 6 
Japan), and cultured to sub-confluency in CEM. To enhance stratification, cells 7 
were grown in KCM medium supplemented with 20 ng/mL KGF and 10 μM Y-8 
27632. Cells were cultured for a total of 16–18 days, and the hiCEC sheet was 9 
harvested by cooling to below 32℃ for 30 min (Hayashi et al. 2010). 10 
 11 
2.8 Cytospin experiments 12 
For immunofluorescence staining, sorted cells were adjusted to a density of 2  13 
105 cells/mL, and 200 μL of the cell suspension was centrifuged at 1,000 rpm 14 
for 5 min in a CytospinTM 4 Cytocentrifuge (Thermo Fisher Scientific). 15 
 16 
2.9 Immunofluorescence staining 17 
Cell sheets were embedded in Tissue-Tek® Optimal Cutting Temperature 18 
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compound (Sakura Fineteck, Japan) and sectioned at 10 μm. To assess 1 
pluripotency and visualize p63 KI-hiPS cells, samples were fixed for 20 min at 2 
room temperature in 4% paraformaldehyde, and blocked for 1 h in Tris-buffered 3 
saline (TBS, Takara Bio) containing 5% donkey serum (Jackson 4 
ImmunoResearch Laboratories, Inc.) and 0.3% Triton X-100 (Wako). Samples 5 
were then probed overnight at 4℃ with antibodies against NANOG (Abcam 6 
ab109250), OCT 3/4 (Abcam ab19857), SSEA-4 (Abcam ab16287) and TRA-1-7 
60 (BD Pharmingen 560173) in TBS containing 1% donkey serum and 0.3% 8 
Triton X-100. Subsequently, samples were labeled for 1 h at room temperature 9 
with secondary antibodies conjugated to Alexa Flour 488, 568, and 647 10 
(Thermo Fisher Scientific). Cells were counterstained with Hoechst 33342 11 
(Molecular Probes) to visualize the nuclei and imaged by fluorescence 12 
microscopy (Axio Observer. D1, Carl Zeiss). 13 
 14 
2.10 Hematoxylin and eosin staining 15 
hiCEC sheets derived from p63 KI-hiPS cells were fixed with 10% formaldehyde 16 
neutral buffer solution (Wako), sectioned in paraffin at 3 μm, stained with 17 
hematoxylin and eosin following deparaffinization and hydration, and imaged 18 
14 
 
under a microscope (Axio Imager. A2, Carl Zeiss). 1 
 2 
2.11 Alkaline phosphatase staining 3 
Cells were stained for 10 min at room temperature with a chromogenic 4 
substrate, which consisted of 4.5 μL NBT (75 mg/mL) in 70% 5 
dimethylformamide and 3.5 μL BCIP (50 mg/mL) in 100% dimethylformamide, 6 
diluted in 1 mL 100 mM Tris-HCl pH 9.5, 100 mM NaCl, and 50 mM MgCl2. 7 
Staining was stopped by washing with phosphate-buffered saline, and cells 8 
were fixed for 30 min at 4℃ with 4% paraformaldehyde, air dried, and imaged 9 
on an EVOS FL Auto imaging system (Thermo Fisher Scientific). 10 
 11 
2.12 qRT-PCR experiments 12 
Differentiated hiPS cells were harvested at specific time periods and lysed in 13 
QIAzol reagent (Qiagen, Valencia, CA). Total RNA was extracted and reverse-14 
transcription was performed using the SuperScript III First-Strand Synthesis 15 
System for qRT-PCR (Thermo Fisher Scientific), and synthesized cDNA was 16 
amplified in duplicate on an ABI Prism 7500 Fast Sequence Detection System 17 
(Thermo Fisher Scientific) using TaqMan Fast Universal PCR Master Mix 18 
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(Applied Biosystems) or SYBR Premix Dimer Eraser (Takara Bio). Targets were 1 
amplified with TaqMan MGB probes assays against ΔNp63 (Hs00978339_m1), 2 
p63α (Hs00978338_m1), TAp63 (Hs00978349_m1), and GAPDH 3 
(HS99999905_m1). EGFP was amplified using the EGFP-Fwd (5-4 
TATATCATGGCCGACAAGCA-3) and EGFP-Rev (5-CTGGGTGCTCAGGTA 5 
GTGGT-3) primers and detected with SYBR Green. Thermocycling conditions 6 
for the TaqMan reactions consisted of an initial cycle at 95℃ for 20 s, and 45 7 
cycles at 95℃ for 3 s and 60℃ for 30 s, while the SYBR green reactions 8 
consisted of an initial cycle at 95℃ for 30 s, and 40 cycles at 95℃ for 3 s, 65℃ 9 
for 30 s, and 72℃ for 30 s. 10 
 11 
3. Results 12 
3.1 Establishing p63 KI-hiPS cells 13 
A pair of TALENs was designed to target sites immediately upstream of the stop 14 
codon in the last exon (exon14) of p63 (Figure 1A, B). The cleavage efficiency, 15 
as measured by single-strand annealing (SSA) (Sakuma et al. 2013), was 16 
greater than that of the positive control HPRT1 and comparable to that of the 17 
positive control HPRT-NC, suggesting an adequate genome-cleavage event 18 
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occurred efficiently (Figure 1C). The most abundant isoform in corneal 1 
epithelium in vivo was detected ΔNp63α isoform by using a specific probe for 2 
ΔNp63α and TAp63α isoform only (Figure 1D) (Di lorio et al. 2005; Krishnan et 3 
al. 2010). Therefore, the levels of p63α were essentially the same as that of 4 
ΔNp63α in corneal epithelium. 5 
The donor vector, which encodes a p63-P2A peptide-EGFP-neomycin 6 
cassette, was electroporated with TALEN plasmids into 1383D2 hiPS cells (wild 7 
type ; WT) to insert the EGFP gene into the target region of p63 via homologous 8 
recombination. Transformants were selected on neomycin for 10–12 days and 9 
genotyped by PCR. Nine of 24 clones (37.5%) were heterozygous KIs, one of 10 
24 clones (4.2%) was a homozygous KI, and the remaining clones were either 11 
WT or were not successfully genotyped (Figure 1E, Table 1). The homozygous 12 
KI clone (clone #47), in which the p63-EGFP-neomycin cassette was knocked-13 
in into both alleles, was verified by sequencing and expanded. In KI cells, p63 14 
was fused to EGFP via the self-cleaved 22 amino acid linker of the 2A peptide 15 
(Kim et al. 2011). Accordingly, p63 (63 kDa) fused to the 2A peptide was 16 
detectable by western blot analysis in these cells, along with free EGFP (27 17 
kDa, Figure 1F). Moreover, p63-2A-EGFP as an uncleaved band was not 18 
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detected. Collectively, these results indicated that the p63 TALENs were highly 1 
specific, that EGFP was integrated into the target site in p63, and that 2A 2 
peptide cleavage between p63 and EGFP was sufficiently efficient for detection 3 
purposes (Chan et al. 2011). 4 
 5 
3.2 Expression of pluripotent stem cell markers in p63 KI-hiPS cells 6 
Pluripotency was assessed by measuring alkaline phosphatase activity and by 7 
performing immunofluorescence staining. Both p63 KI-iPS cells and WT cells 8 
expressed alkaline phosphatase, suggestive of an undifferentiated state (Figure 9 
2A). In addition, the pluripotent stem cell markers OCT 3/4 and NANOG, as well 10 
as the cell surface markers SSEA-4 and tumor-related antigen (TRA) -1-60 11 
were all expressed in KI-hiPS cells (Figure 2B). 12 
 13 
3.3 Differentiation of p63 KI-hiPS cells into ocular surface ectodermal cells 14 
p63 KI-hiPS cells were formed within the 1st through 4th zones as the SEAM 15 
structure after 6 weeks of differentiation (Figure 3A). As assessed by 16 
immunofluorescence staining, p63 was clearly coexpressed with EGFP in 17 
epithelial cells in the 3rd and 4th zones (Figure 3B). The ocular cell marker PAX6 18 
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was also expressed in those zones after 6 weeks of differentiation (Figure 3C).  1 
p63 expression was visualized via EGFP under a microscopy after 2 2 
weeks of differentiation. p63 expression was detectable via EGFP in an average 3 
of 6.77 ± 1.43% cells at 2 weeks after differentiation (n = 17) and in an 4 
average of 2.30 ± 1.00% cells at 4 weeks (n = 8). Between 7 and 8 weeks of 5 
differentiation, the 1st and 2nd zones in the SEAM were removed by manual 6 
pipetting to retain the epithelial cells only. After pipetting and culturing in corneal 7 
differentiation medium (CDM), the fraction of epithelial cells expressing p63 8 
then dramatically increased to an average of 42.11 ± 10.64% at 10 weeks of 9 
differentiation (n = 7) (Figure 4A). 10 
Quantitative real-time reverse-transcriptase PCR (qRT-PCR) results 11 
confirmed that p63 expression correlated with EGFP expression in KI-hiPS 12 
cells. As in parental cells, the predominant isoform in KI-hiPS cells was ΔNp63, 13 
which showed the same expression as p63α, whereas TAp63 was barely 14 
detected (Figure 4B). 15 
 16 
3.4 Isolation of p63 KI-hiPS ocular surface ectodermal cells 17 
After culturing hiPS-derived ocular surface ectodermal cells in the 3rd and 4th 18 
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zones for 10–12 weeks, corneal epithelial cells were isolated by fluorescence-1 
activated cell sorting (FACS) based on positive expression of p63 based on 2 
EGFP fluorescence and the corneal epithelial markers SSEA-4 and ITGB-4. On 3 
average, 11.66 ± 5.03% of the cells were human iPS cell-derived corneal 4 
epithelial cells (hiCECs) (n = 7) (Figure 5A). Immunostaining confirmed 5 
coexpression of p63 and EGFP (Figure 5B). The isolated hiCECs were further 6 
cultured for tissue reconstruction of a hiCEC-derived cell sheet. During 7 
culturing, EGFP-positive cells were observed by fluorescence microscopy 8 
(Figure 5C). FACS analysis indicated that 48.2% of differentiated cells 9 
expressed both p63 and ITGB-4, with 94.3% of ITGB-4+ cells also expressing 10 
p63. Conversely, 97.4% of p63+ cells also expressed ITGB-4 (Figure S1A), 11 
although sorting based on SSEA-4 and ITGB-4 indicated that 92.3% and 44.0% 12 
of cells expressing or strongly expressing SSEA-4 also expressed p63 (Figure 13 
S1B). 14 
 15 
3.5 Cell sheets derived from p63 KI-hiPS cells 16 
Cell sheets were easily detached without any damage by reducing the 17 
temperature from 37℃ to 20℃ (Figure 6A). The cell sheets consisted of tightly 18 
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packed cobblestone-like structures, as observed in the corneal epithelium in 1 
vivo, and were visualized as EGFP-positive cells (Figure 6B). Hematoxylin and 2 
eosin staining revealed that the sheet had 3–4 layers of stratification, similar to 3 
corneal epithelial cells in vivo (Figure 6C). For immunohistochemical staining, 4 
EGFP-positive cells were present, in which p63 was coexpressed. The major 5 
corneal epithelial markers keratin 3 (K3/K76), keratin 12 (K12), and PAX6 were 6 
clearly expressed, although the conjunctival epithelial marker keratin 13 (K13) 7 
was barely detectable. The ocular surface marker MUC16 and the stratified 8 
epithelial marker keratin 14 (K14) were also strongly expressed. However, the 9 
epidermal marker keratin 10 (K10) was not expressed. ZO-1, a marker of tight 10 
junctions mediating cell-cell adhesion, was detected, suggesting that the cell 11 
sheet was capable of a barrier function (Figure 6D). 12 
 13 
4. Discussion 14 
In this study, a p63 KI-hiPS cell line was successfully established by using 15 
TALEN-mediated genome editing. We confirmed that EGFP was coexpressed 16 
with p63 as designed, which enabled us to track p63 expression via EGFP 17 
fluorescence. Labeling hiPS and human embryonic stem cells in this manner 18 
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was previously used to track differentiated and pluripotent cells (Eiraku et al. 1 
2011; Nakano et al. 2012; Sekine et al. 2014).  2 
hiPS cells have potential to be differentiated into any type of cells. To 3 
evaluate KI-hiPS cells, it was induced differentiation into epithelial according to 4 
a protocol described by Hayashi et al. (2016). After differentiation, we observed 5 
approximately 11.66% of hiCECs, a level similar to the 14.1% observed using 6 
WT hiPS cells (Hayashi et al. 2016). This result indicated that KI-hiPS cells 7 
showed comparable differentiation potential relative to corneal epithelial. 8 
Despite technical challenges, we succeeded in genetically manipulating 9 
feeder-free hiPS cells, noting that both hiPS cells and hES cells (Byrne et al. 10 
2014) exhibited specific characteristics in terms of growth rates, timing of 11 
passaging, morphology, differentiation tendency, antibiotic resistance, and 12 
optimal electroporation conditions. Maintaining the quality of hiPS cell 13 
pluripotency is essential for further induction experiments. 14 
Previously, TRA-1-60 was used to separate undifferentiated hiPS cells 15 
from corneal epithelial cells by FACS (Hayashi et al. 2016). In contrast, TRA-1-16 
60 is dispensable for isolating epithelium derived from KI-hiPS cells, since 17 
differentiated cells are conveniently labeled with EGFP. Of note, FACS analysis 18 
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suggested that p63-expressing cells could serve as surrogate cells for ITGB-4 1 
positive cells. On the other hand, sorting based on SSEA-4 and ITGB-4 clearly 2 
indicated that p63 was expressed at different levels. As p63 tended to be 3 
expressed in immature epithelial cells, fractions enriched in cells strongly 4 
expressing SSEA-4 should also be enriched in mature corneal epithelial cells. In 5 
addition, we noted that most SSEA-4+ cells also expressed the corneal 6 
differentiation marker keratin 12 (Hayashi et al. 2016), indicating that SSEA-4 is 7 
useful as a corneal differentiation marker. Thus, selecting SSEA-4+ and p63+ 8 
cells from immature epithelium was more accurate and selective for isolating 9 
corneal epithelial cells. 10 
The eye is one of the 5 sensory organs, and is essential for vision. 11 
Corneal diseases such as limbal stem cell deficiency lead to blindness caused 12 
by the failure to maintain corneal transparency. Fortunately, such diseases are 13 
treatable, and vision can be restored as long as the retina and the optic nerve 14 
are functional. For example, cell sheets similar to the corneal epithelium and 15 
obtained hiPS cells can potentially be used in corneal transplants, although the 16 
fate of an iPS-derived graft after transplantation is largely unknown at present. 17 
By transplanting EGFP-labeled cell sheets to animal models, recovery can be 18 
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tracked long-term in vivo and ex vivo. Indeed, we anticipate that p63 KI-hiPS 1 
cells may prove useful in developing novel therapies such as ocular surface 2 
regeneration for translational research. 3 
This is the first report describing the isolation of epithelial stem cells from 4 
differentiated hiPS cells. These stem cells formed functional tissues and have 5 
significant potential for further analysis of epithelial stem cell functions, epithelial 6 
development, and experimental transplantation. In particular, p63 KI-hiPS cells 7 
may enable further investigation of corneal epithelial differentiation, analysis of 8 
epithelial cell lineages, and identification of unknown p63 targets, since p63 is 9 
abundantly expressed during ectodermal and epidermal development, and in 10 
maintaining proliferative stem cells. For example, these cells may clarify how 11 
p63 integrates multiple signaling pathways such as those regulated by BMP, 12 
Wnt and TGFβ (Aberdam et al. 2007; Yoh and Prywes 2015; Zhang et al. 2015), 13 
in order to facilitate commitment and self-renewal during development. 14 
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Figure legends 2 
Figure 1. Generation of p63 KI-hiPS cells using TALEN-mediated genome 3 
editing. (A) Structure of the human p63 gene and TALEN recognition sites. p63 4 
consists of an N-terminal transactivation domain (TA), a DNA-binding domain, a 5 
C-terminal oligomerization domain (Oligo), and other C-terminal domains 6 
including a second transactivation domain (TA), a sterile alpha motif domain 7 
(SAM), and a transactivation inhibitory domain (TID). Alternative splicing at the 8 
C-terminus generates the α, β, and γ isoforms. (B) Gene KI into the human 9 
p63α gene. The TALEN recognition sites for gene targeting were immediately 10 
upstream of the stop codon in the last exon of p63 (exon 14). The insert 11 
encoded a p63-2A peptide fused to an EGFP-neomycin cassette, which was 12 
flanked by a 550-bp homologous arms at both ends. (C) Cleavage efficiency of 13 
the p63 TALEN pairs in HEK293T cells, as measured by single-strand 14 
annealing. p63 TALENs had comparable genome-cleavage efficiency relative to 15 
those of the HPRT1 and HPRT1-NC TALENs. The data are shown as the mean 16 
± SD (n = 3). (D) Expression of major p63 isoforms in the corneal epithelium in 17 
vivo. The major p63 isoform was ΔNp63α. The data are shown as the mean ± 18 
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SD (n = 3). (E) PCR genotyping of p63 KI-hiPS cells. WT and KI p63 are 1,604 1 
bps and 4,247 bps, respectively. Clones 42, 53, and 48 were WT; clones 51, 54, 2 
and 60 were heterozygous KIs; and clone 47 was a homozygous KI. (F) 2A 3 
peptide cleavage in p63 KI-hiPS cells. The p63-2A fusion and EGFP were 4 
detected only in KI cells. GAPDH was used as a loading control. 5 
 6 
Figure 2. Pluripotency of p63 KI-hiPS cells. (A) Alkaline phosphatase staining 7 
indicated pluripotency in both WT (left) and KI cells (right). The top panels are 8 
macro photographs, while the bottom panels show single, stained colonies 9 
(Scale bars, 1 cm (top) and 400 μm (bottom)). (B) Immunohistochemical 10 
staining. The pluripotency markers OCT3/4, NANOG, TRA-1-60, and SSEA-4 11 
were detected in KI cells (Scale bar, 100 μm). 12 
 13 
Figure 3. Differentiation of p63 KI-hiPS cells into ocular epithelial cells.  14 
(A) Differentiation of p63 KI-hiPS cells into ocular cells in the SEAM structure. 15 
Representative image of undifferentiated hiPS cells at day 0 (left; scale bar, 200 16 
μm), and representative SEAM structures with the 1st, 2nd, 3rd, and 4th zones 17 
after 6–7 weeks of differentiation (right; scale bar, 1000 μm). p63 expression 18 
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was detected in the 3rd zone. (B) Co-expression of p63 (red) and EGFP (green) 1 
in the 3rd and 4th zones in a SEAM after 6–7 weeks in culture. The top panels 2 
show a SEAM structure with all zones, and the bottom panels are the same 3 
structures show at a higher magnification (Scale bars, 100 μm). (C) Co-4 
expression of p63 (green) and PAX6 (red) after 6–7 weeks in culture. p63 was 5 
expressed in the 3rd and 4th zones, while PAX6 was expressed in the 2nd and 3rd 6 
zones. Cells expressing both p63 and PAX6 were fated to form corneal 7 
epithelium (Scale bar, 100 μm). 8 
 9 
Figure 4. Expression of p63 isoforms in ocular cells differentiated from p63 KI-10 
hiPS cells. (A) Fluorescence-activated cell sorting based on p63 expression at 11 
0, 2, 4, and 10 weeks of differentiation. The plots are representative of 17, 8, 12 
and 7 independent samples at 2, 4, and 10 weeks of differentiation, 13 
respectively. The plots are indicated of KI (green) and WT (dotted black line) 14 
cells. (B) qRT-PCR of p63 isoforms and correlation with EGFP. ΔNp63 and 15 
p63α were detected in EGFP+ cells at 4 and 10 weeks of differentiation, but 16 
TAp63 was barely expressed, suggesting that ΔNp63α is the predominant 17 




Figure 5. Isolation of corneal epithelial cells co-expressing p63 and EGFP. (A) 2 
Flow cytometric analysis of p63 and ITGB-4 at 10 weeks of differentiation. p63+ 3 
cells were sorted based on ITGB-4 expression, and p63+ SSEA-4+ ITGB-4+ 4 
were considered to be human iPS induced corneal epithelial cells (hiCECs). 5 
These cells were seeded in a temperature-responsive dish to culture a cell 6 
sheet. (B) Coexpression of p63 and EGFP in single epithelial cells. Cells were 7 
collected by performing a cytospin and then immunostained with an anti-p63 8 
antibody (Scale bar, 100 μm). (C) Isolated p63+ SSEA-4+ ITGB-4+ p63+ cells 9 
were visualized for green fluorescence at day 4 (Scale bar, 100 μm). 10 
 11 
Figure 6. Characterization of cell sheets derived from p63 KI-hiPS cells. (A) 12 
Macro image of a harvested hiCEC sheet (Scale bar, 0.5 mm). (B) Phase-13 
contrast imaging of (left) and EGFP+ cells (right) in an hiCEC sheet grown on a 14 
temperature-responsive dish (Scale bar, 100 μm). (C) Cell sheet stained with 15 
hematoxylin and eosin (Scale bar, 50 μm). (D) Immunohistochemical analysis of 16 
EGFP (green), keratin 12, p63, PAX6, MUC16, keratin 14, keratin 3/76, keratin 17 
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13, ZO-1 and keratin 10 (red) expression. Nuclei are stained blue (Scale bar, 50 1 
μm). 2 
 3 
Supplemental information 4 
Supplemental Figure 1. Coexpression of p63 and ITGB-4, and 5 
characterization of p63+ cells. (A) Flow cytometric analysis of p63 and ITGB-4 6 
after 10 weeks of differentiation. (B) p63+ cells in ITGB-4+ cells, and ITGB-4+ 7 
cells in p63+ cells. (C) Flow cytometric analysis of SSEA-4 and ITGB-4 after 10 8 
weeks of differentiation, with cells in fractions 1 and 2 considered to express 9 
and strongly express SSEA-4, respectively. (D) Fraction of p63+ cells in hiCEC 10 
fractions 1 (left) and 2 (right). 11 
